Overview
David Schomas is a Radiation Oncologist in Oklahoma City, Oklahoma. Dr. Schomas is rated as an Advanced provider by MediFind in the treatment of Gliosarcoma. His top areas of expertise are Pleuropulmonary Blastoma, Lung Cancer, Breast Cancer, and Astrocytoma. Dr. Schomas is currently accepting new patients.
His clinical research consists of co-authoring 11 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- INSURANCE PLAN
- MEDICARE MAPD
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- HMO
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
4300 W Memorial Rd, Oklahoma City, OK 73120
4300 Mcauley Blvd, Oklahoma City, OK 73120
1011 14th Ave Nw, Ardmore, OK 73401
430 N Monte Vista St, Ada, OK 74820
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Mercy Clinic Oklahoma Communities
Astrid Morrison is a Radiation Oncologist and a Radiologist in Oklahoma City, Oklahoma. Dr. Morrison is rated as a Distinguished provider by MediFind in the treatment of Gliosarcoma. Her top areas of expertise are Posterior Fossa Tumor, Meningioma, Radiation Induced Meningioma, and Lung Cancer. Dr. Morrison is currently accepting new patients.
Ou Health Partners Inc
Tyler Gunter is a Radiation Oncologist in Oklahoma City, Oklahoma. Dr. Gunter is rated as an Advanced provider by MediFind in the treatment of Gliosarcoma. His top areas of expertise are Prostate Cancer, Posterior Fossa Tumor, Primitive Neuroectodermal Tumor (PNET), and Ependymoma. Dr. Gunter is currently accepting new patients.
Ou Health Partners Inc
Jerry Jaboin is a Radiation Oncologist in Oklahoma City, Oklahoma. Dr. Jaboin is rated as a Distinguished provider by MediFind in the treatment of Gliosarcoma. His top areas of expertise are Meningioma, Metastatic Brain Tumor, Brain Tumor, Glioblastoma, and Orchiectomy. Dr. Jaboin is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Lung CancerDr. Schomas isDistinguished. Learn about Lung Cancer.
- Pleuropulmonary BlastomaDr. Schomas isDistinguished. Learn about Pleuropulmonary Blastoma.
- Advanced
- ALK-Positive Non-Small Cell Lung Cancer
- AstrocytomaDr. Schomas isAdvanced. Learn about Astrocytoma.
- Atypical Teratoid Rhabdoid Tumor (ATRT)
- Brain TumorDr. Schomas isAdvanced. Learn about Brain Tumor.
- Breast CancerDr. Schomas isAdvanced. Learn about Breast Cancer.
- EGFR Positive Lung CancerDr. Schomas isAdvanced. Learn about EGFR Positive Lung Cancer.
- Experienced
- Acoustic NeuromaDr. Schomas isExperienced. Learn about Acoustic Neuroma.
- Adult Soft Tissue SarcomaDr. Schomas isExperienced. Learn about Adult Soft Tissue Sarcoma.
- Ampullary CancerDr. Schomas isExperienced. Learn about Ampullary Cancer.
- Anal CancerDr. Schomas isExperienced. Learn about Anal Cancer.
- Anaplastic Thyroid CancerDr. Schomas isExperienced. Learn about Anaplastic Thyroid Cancer.
- AngiosarcomaDr. Schomas isExperienced. Learn about Angiosarcoma.